Loading…
Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum
Sterol 14α-demethylases from Cytochrome P450 family (CYP51s) are essential enzymes in sterol biosynthesis and well-known as the target of antifungal drugs. The 3D structure of CYP51A from (PiCYP51A) was constructed through homology modeling based on the crystal structure of human CYP51A (PDB: 3LD6)....
Saved in:
Published in: | Marine drugs 2017-04, Vol.15 (4), p.107 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c472t-f986b69dc880f0ecacff6ffc2fd69139b8987ad7dd79b617d62796daf36a75fe3 |
---|---|
cites | cdi_FETCH-LOGICAL-c472t-f986b69dc880f0ecacff6ffc2fd69139b8987ad7dd79b617d62796daf36a75fe3 |
container_end_page | |
container_issue | 4 |
container_start_page | 107 |
container_title | Marine drugs |
container_volume | 15 |
creator | Yuan, Yongze Han, Rui Cao, Qianwen Yu, Jinhui Mao, Jiali Zhang, Tingfu Wang, Shengqiang Niu, Yuhui Liu, Deli |
description | Sterol 14α-demethylases from Cytochrome P450 family (CYP51s) are essential enzymes in sterol biosynthesis and well-known as the target of antifungal drugs. The 3D structure of CYP51A from
(PiCYP51A) was constructed through homology modeling based on the crystal structure of human CYP51A (PDB: 3LD6). Molecular dynamics (MD) simulation was operated to relax the initial model and followed by quality assessment using PROCHECK program. On the basis of the docking information on the currently available CYP51s with the patent demethylase inhibitors (DMIs), pharmacophore-based virtual screening combined with docking analysis was performed to pick out twelve new compounds from ZINC database. Six hits revealed in the ligand database suggested potential ability to inhibit PiCYP51A. Compared to patent fungicide triazolone, the top three lead compounds had similar or higher affinity with the target enzyme, and accordingly, exhibited comparable or lower EC
values to
isolates. The results could provide references for de novo antifungal drug design. |
doi_str_mv | 10.3390/md15040107 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_80b9b57d62e04491bcf2e18116c0ac06</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_80b9b57d62e04491bcf2e18116c0ac06</doaj_id><sourcerecordid>1899835708</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-f986b69dc880f0ecacff6ffc2fd69139b8987ad7dd79b617d62796daf36a75fe3</originalsourceid><addsrcrecordid>eNpdkluLFDEQRhtR3HX1xR8gAV9EaE066VxehHG8DSw64AV8CtW5zGRMd2aT7oX99_Y467rrU4WqU4cifFX1lOBXlCr8urekxQwTLO5Vp4RzXM9tcf_W-6R6VMoOY9pKxR5WJ42kQhFOT6uy3kLuwaT9NmVXv4XiLPoR8jhBRF9Ndm4IwwYljz6nSxfRatiGLowpFwSDRe-S-XWYLwaIVyUU5FNGy5_rliyQz6lH63nfhBjD1KMwQgxm6h9XDzzE4p5c17Pq-4f335af6vMvH1fLxXltmGjG2ivJO66skRJ77AwY77n3pvGWK0JVJ5UUYIW1QnWcCMsbobgFTzmI1jt6Vq2OXptgp_c59JCvdIKg_zRS3mjIYzDRaYk71bUHhcOMKdIZ3zgiCeEGg8F8dr05uvZT1ztr3DBmiHekdydD2OpNutQtw7Jp6Sx4cS3I6WJyZdR9KMbFCINLU9FESsYE45TN6PP_0F2a8vzDB0opSVuB5Uy9PFImp1Ky8zfHEKwPudD_cjHDz26ff4P-DQL9DW2VtEQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899835708</pqid></control><display><type>article</type><title>Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Yuan, Yongze ; Han, Rui ; Cao, Qianwen ; Yu, Jinhui ; Mao, Jiali ; Zhang, Tingfu ; Wang, Shengqiang ; Niu, Yuhui ; Liu, Deli</creator><creatorcontrib>Yuan, Yongze ; Han, Rui ; Cao, Qianwen ; Yu, Jinhui ; Mao, Jiali ; Zhang, Tingfu ; Wang, Shengqiang ; Niu, Yuhui ; Liu, Deli</creatorcontrib><description>Sterol 14α-demethylases from Cytochrome P450 family (CYP51s) are essential enzymes in sterol biosynthesis and well-known as the target of antifungal drugs. The 3D structure of CYP51A from
(PiCYP51A) was constructed through homology modeling based on the crystal structure of human CYP51A (PDB: 3LD6). Molecular dynamics (MD) simulation was operated to relax the initial model and followed by quality assessment using PROCHECK program. On the basis of the docking information on the currently available CYP51s with the patent demethylase inhibitors (DMIs), pharmacophore-based virtual screening combined with docking analysis was performed to pick out twelve new compounds from ZINC database. Six hits revealed in the ligand database suggested potential ability to inhibit PiCYP51A. Compared to patent fungicide triazolone, the top three lead compounds had similar or higher affinity with the target enzyme, and accordingly, exhibited comparable or lower EC
values to
isolates. The results could provide references for de novo antifungal drug design.</description><identifier>ISSN: 1660-3397</identifier><identifier>EISSN: 1660-3397</identifier><identifier>DOI: 10.3390/md15040107</identifier><identifier>PMID: 28379163</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antifungal Agents - metabolism ; Biosynthesis ; Crystal structure ; Cytochrome P-450 Enzyme System - metabolism ; Cytochrome P450 ; Cytochromes ; demethylase inhibitors ; Drug Design ; Drug development ; Drugs ; Dynamics ; Enzymes ; Fungal Proteins - metabolism ; Fungicides ; Homology ; Humans ; Inhibitors ; Lead compounds ; Ligands ; Modelling ; molecular docking ; Molecular Docking Simulation - methods ; Molecular dynamics ; Molecular Dynamics Simulation ; Penicillium - metabolism ; Penicillium italicum ; pharmacophore ; PiCYP51A ; Quality control ; Simulation ; Sterols ; virtual screening ; Zinc</subject><ispartof>Marine drugs, 2017-04, Vol.15 (4), p.107</ispartof><rights>Copyright MDPI AG 2017</rights><rights>2017 by the authors. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-f986b69dc880f0ecacff6ffc2fd69139b8987ad7dd79b617d62796daf36a75fe3</citedby><cites>FETCH-LOGICAL-c472t-f986b69dc880f0ecacff6ffc2fd69139b8987ad7dd79b617d62796daf36a75fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1899835708/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1899835708?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28379163$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yuan, Yongze</creatorcontrib><creatorcontrib>Han, Rui</creatorcontrib><creatorcontrib>Cao, Qianwen</creatorcontrib><creatorcontrib>Yu, Jinhui</creatorcontrib><creatorcontrib>Mao, Jiali</creatorcontrib><creatorcontrib>Zhang, Tingfu</creatorcontrib><creatorcontrib>Wang, Shengqiang</creatorcontrib><creatorcontrib>Niu, Yuhui</creatorcontrib><creatorcontrib>Liu, Deli</creatorcontrib><title>Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum</title><title>Marine drugs</title><addtitle>Mar Drugs</addtitle><description>Sterol 14α-demethylases from Cytochrome P450 family (CYP51s) are essential enzymes in sterol biosynthesis and well-known as the target of antifungal drugs. The 3D structure of CYP51A from
(PiCYP51A) was constructed through homology modeling based on the crystal structure of human CYP51A (PDB: 3LD6). Molecular dynamics (MD) simulation was operated to relax the initial model and followed by quality assessment using PROCHECK program. On the basis of the docking information on the currently available CYP51s with the patent demethylase inhibitors (DMIs), pharmacophore-based virtual screening combined with docking analysis was performed to pick out twelve new compounds from ZINC database. Six hits revealed in the ligand database suggested potential ability to inhibit PiCYP51A. Compared to patent fungicide triazolone, the top three lead compounds had similar or higher affinity with the target enzyme, and accordingly, exhibited comparable or lower EC
values to
isolates. The results could provide references for de novo antifungal drug design.</description><subject>Antifungal Agents - metabolism</subject><subject>Biosynthesis</subject><subject>Crystal structure</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Cytochrome P450</subject><subject>Cytochromes</subject><subject>demethylase inhibitors</subject><subject>Drug Design</subject><subject>Drug development</subject><subject>Drugs</subject><subject>Dynamics</subject><subject>Enzymes</subject><subject>Fungal Proteins - metabolism</subject><subject>Fungicides</subject><subject>Homology</subject><subject>Humans</subject><subject>Inhibitors</subject><subject>Lead compounds</subject><subject>Ligands</subject><subject>Modelling</subject><subject>molecular docking</subject><subject>Molecular Docking Simulation - methods</subject><subject>Molecular dynamics</subject><subject>Molecular Dynamics Simulation</subject><subject>Penicillium - metabolism</subject><subject>Penicillium italicum</subject><subject>pharmacophore</subject><subject>PiCYP51A</subject><subject>Quality control</subject><subject>Simulation</subject><subject>Sterols</subject><subject>virtual screening</subject><subject>Zinc</subject><issn>1660-3397</issn><issn>1660-3397</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkluLFDEQRhtR3HX1xR8gAV9EaE066VxehHG8DSw64AV8CtW5zGRMd2aT7oX99_Y467rrU4WqU4cifFX1lOBXlCr8urekxQwTLO5Vp4RzXM9tcf_W-6R6VMoOY9pKxR5WJ42kQhFOT6uy3kLuwaT9NmVXv4XiLPoR8jhBRF9Ndm4IwwYljz6nSxfRatiGLowpFwSDRe-S-XWYLwaIVyUU5FNGy5_rliyQz6lH63nfhBjD1KMwQgxm6h9XDzzE4p5c17Pq-4f335af6vMvH1fLxXltmGjG2ivJO66skRJ77AwY77n3pvGWK0JVJ5UUYIW1QnWcCMsbobgFTzmI1jt6Vq2OXptgp_c59JCvdIKg_zRS3mjIYzDRaYk71bUHhcOMKdIZ3zgiCeEGg8F8dr05uvZT1ztr3DBmiHekdydD2OpNutQtw7Jp6Sx4cS3I6WJyZdR9KMbFCINLU9FESsYE45TN6PP_0F2a8vzDB0opSVuB5Uy9PFImp1Ky8zfHEKwPudD_cjHDz26ff4P-DQL9DW2VtEQ</recordid><startdate>20170405</startdate><enddate>20170405</enddate><creator>Yuan, Yongze</creator><creator>Han, Rui</creator><creator>Cao, Qianwen</creator><creator>Yu, Jinhui</creator><creator>Mao, Jiali</creator><creator>Zhang, Tingfu</creator><creator>Wang, Shengqiang</creator><creator>Niu, Yuhui</creator><creator>Liu, Deli</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T7</scope><scope>7TN</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H95</scope><scope>H99</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L.F</scope><scope>L.G</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PCBAR</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170405</creationdate><title>Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum</title><author>Yuan, Yongze ; Han, Rui ; Cao, Qianwen ; Yu, Jinhui ; Mao, Jiali ; Zhang, Tingfu ; Wang, Shengqiang ; Niu, Yuhui ; Liu, Deli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-f986b69dc880f0ecacff6ffc2fd69139b8987ad7dd79b617d62796daf36a75fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antifungal Agents - metabolism</topic><topic>Biosynthesis</topic><topic>Crystal structure</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Cytochrome P450</topic><topic>Cytochromes</topic><topic>demethylase inhibitors</topic><topic>Drug Design</topic><topic>Drug development</topic><topic>Drugs</topic><topic>Dynamics</topic><topic>Enzymes</topic><topic>Fungal Proteins - metabolism</topic><topic>Fungicides</topic><topic>Homology</topic><topic>Humans</topic><topic>Inhibitors</topic><topic>Lead compounds</topic><topic>Ligands</topic><topic>Modelling</topic><topic>molecular docking</topic><topic>Molecular Docking Simulation - methods</topic><topic>Molecular dynamics</topic><topic>Molecular Dynamics Simulation</topic><topic>Penicillium - metabolism</topic><topic>Penicillium italicum</topic><topic>pharmacophore</topic><topic>PiCYP51A</topic><topic>Quality control</topic><topic>Simulation</topic><topic>Sterols</topic><topic>virtual screening</topic><topic>Zinc</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuan, Yongze</creatorcontrib><creatorcontrib>Han, Rui</creatorcontrib><creatorcontrib>Cao, Qianwen</creatorcontrib><creatorcontrib>Yu, Jinhui</creatorcontrib><creatorcontrib>Mao, Jiali</creatorcontrib><creatorcontrib>Zhang, Tingfu</creatorcontrib><creatorcontrib>Wang, Shengqiang</creatorcontrib><creatorcontrib>Niu, Yuhui</creatorcontrib><creatorcontrib>Liu, Deli</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Oceanic Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric & Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>ASFA: Marine Biotechnology Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric & Aquatic Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Marine drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuan, Yongze</au><au>Han, Rui</au><au>Cao, Qianwen</au><au>Yu, Jinhui</au><au>Mao, Jiali</au><au>Zhang, Tingfu</au><au>Wang, Shengqiang</au><au>Niu, Yuhui</au><au>Liu, Deli</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum</atitle><jtitle>Marine drugs</jtitle><addtitle>Mar Drugs</addtitle><date>2017-04-05</date><risdate>2017</risdate><volume>15</volume><issue>4</issue><spage>107</spage><pages>107-</pages><issn>1660-3397</issn><eissn>1660-3397</eissn><abstract>Sterol 14α-demethylases from Cytochrome P450 family (CYP51s) are essential enzymes in sterol biosynthesis and well-known as the target of antifungal drugs. The 3D structure of CYP51A from
(PiCYP51A) was constructed through homology modeling based on the crystal structure of human CYP51A (PDB: 3LD6). Molecular dynamics (MD) simulation was operated to relax the initial model and followed by quality assessment using PROCHECK program. On the basis of the docking information on the currently available CYP51s with the patent demethylase inhibitors (DMIs), pharmacophore-based virtual screening combined with docking analysis was performed to pick out twelve new compounds from ZINC database. Six hits revealed in the ligand database suggested potential ability to inhibit PiCYP51A. Compared to patent fungicide triazolone, the top three lead compounds had similar or higher affinity with the target enzyme, and accordingly, exhibited comparable or lower EC
values to
isolates. The results could provide references for de novo antifungal drug design.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>28379163</pmid><doi>10.3390/md15040107</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1660-3397 |
ispartof | Marine drugs, 2017-04, Vol.15 (4), p.107 |
issn | 1660-3397 1660-3397 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_80b9b57d62e04491bcf2e18116c0ac06 |
source | PubMed (Medline); Publicly Available Content Database |
subjects | Antifungal Agents - metabolism Biosynthesis Crystal structure Cytochrome P-450 Enzyme System - metabolism Cytochrome P450 Cytochromes demethylase inhibitors Drug Design Drug development Drugs Dynamics Enzymes Fungal Proteins - metabolism Fungicides Homology Humans Inhibitors Lead compounds Ligands Modelling molecular docking Molecular Docking Simulation - methods Molecular dynamics Molecular Dynamics Simulation Penicillium - metabolism Penicillium italicum pharmacophore PiCYP51A Quality control Simulation Sterols virtual screening Zinc |
title | Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A08%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacophore-Based%20Virtual%20Screening%20of%20Novel%20Inhibitors%20and%20Docking%20Analysis%20for%20CYP51A%20from%20Penicillium%20italicum&rft.jtitle=Marine%20drugs&rft.au=Yuan,%20Yongze&rft.date=2017-04-05&rft.volume=15&rft.issue=4&rft.spage=107&rft.pages=107-&rft.issn=1660-3397&rft.eissn=1660-3397&rft_id=info:doi/10.3390/md15040107&rft_dat=%3Cproquest_doaj_%3E1899835708%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c472t-f986b69dc880f0ecacff6ffc2fd69139b8987ad7dd79b617d62796daf36a75fe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1899835708&rft_id=info:pmid/28379163&rfr_iscdi=true |